ANDREA KEMP: Open Payments
NPI 1265812135 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 7 payments from 5 companies in 2025. Trend: 2023 $675 · 2024 $318 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Alkermes, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
Products named: INGREZZA, FANAPT, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.
Industry payments across AZ — which companies pay providers there.
